Literature DB >> 15825423

In vitro comparison of four aminoglycoside antibiotics: sisomicin, gentamicin, tobramycin, and BB-K8.

M E Levison, D Kaye.   

Abstract

The activity of sisomicin, gentamicin, and tobramycin against 273 clinical bacterial isolates was about equal (except for greater activity of tobramycin against Pseudomonas) and was greater than that of BB-K 8 as determined by antibiotic dilution methods in agar and broth.

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 15825423      PMCID： PMC429032          DOI： 10.1128/AAC.5.6.667

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  A study of the immunocytoadherence test in the serology of experimental sporotrichosis.

Authors:  G D Roberts; H W Larsh
Journal:  J Infect Dis       Date:  1971-09       Impact factor: 5.226

2.  Comparative activity of sisomicin, gentamicin, kanamycin, and tobramycin.

Authors:  J A Waitz; E L Moss; C G Drube; M J Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

3.  Susceptibility of Pseudomonas aeruginosa to gentamicin sulfate in vitro: lack of correlation between disc diffusion and broth dilution sensitivity data.

Authors:  W H Traub
Journal:  Appl Microbiol       Date:  1970-07

4.  Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin.

Authors:  L P Garrod; P M Waterworth
Journal:  J Clin Pathol       Date:  1969-09       Impact factor: 3.411

5.  Comparative in vitro activity of three aminoglycosidic antibiotics: BB-K8, kanamycin, and gentamicin.

Authors:  P K Yu; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191

6.  Sisomicin: evaluation in vitro and comparison with gentamicin and tobramycin.

Authors:  C C Crowe; E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

7.  Activity of five aminoglycoside antibiotics in vitro against gram-negative bacilli and Staphylococcus aureus.

Authors:  L S Young; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191

8.  In vitro evaluation of a new aminoglycoside derivative of kanamycin, a comparison with tobramycin and gentamycin.

Authors:  K Ries; M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

9.  In vitro bactericidal effectiveness of four aminoglycoside antibiotics.

Authors:  P J Hyams; M S Simberkoff; J J Rahal
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191
  9 in total
  13 in total

1.  Penetration of amikacin into the aphakic eye.

Authors:  R T Kasbeer; G A Peyman; D R May; P I Homer
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975-08-04

2.  In vitro activity of netilmicin.

Authors:  J A Smith; J R Morgan; M Mogyoros
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

3.  Sisomicin versus netilmicin: in vitro susceptibility testing.

Authors:  D J Flournoy
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

4.  Comparative nephrotoxicity of gentamicin and tobramycin in rats.

Authors:  D N Gilbert; C Plamp; P Starr; W M Bennet; D C Houghton; G Porter
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

5.  In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.

Authors:  S M Pogwizd; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

6.  Characterization and identification of a novel marine Streptomyces sp. produced antibacterial substance.

Authors:  Yingjian Lu; Xin Dong; Shu Liu; Xiaomei Bie
Journal:  Mar Biotechnol (NY)       Date:  2009-03-11       Impact factor: 3.619

Review 7.  Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

8.  Pharmacokinetics of sisomicin in patients with normal and impaired renal function; its efficacy in urinary tract infection.

Authors:  S Roth; K Naber; M Scheer; G Gruenwaldt; H Lange
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

9.  [Concentration in bone and haematoma of the aminoglycoside antibiotic tobramycin (author's transl)].

Authors:  W Winkelmann; K P Schulitz; H Knothe; B Schoening
Journal:  Infection       Date:  1978       Impact factor: 3.553

10.  Clinical pharmacokinetics of sisomicin: dosage schedules in renal-impaired patients.

Authors:  J C Pechère; M M Pechère; R Dugal
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.